Ebola drug trial starts in Liberia
A trial of a potential drug to treat Ebola has started at
a Medecins Sans Frontieres centre in Liberia.
The antiviral - brincidofovir - is being tested on Ebola patients on a voluntary basis. People who do not consent to it receive standard care.
Oxford University scientists leading the research say initial results are expected in the next few months.
Scientists at Oxford say brincidofovir was chosen because it
is effective against Ebola-infected cells in laboratories, has been deemed safe
in more than 1,000 patients in trials against other viruses and can be given
conveniently as a tablet.
No comments:
Post a Comment